心房颤动导管消融后复发机制的研究进展

摘要/Abstract

中图分类号:

R541.75

费镇涛, 陈牧, 李毅刚. 心房颤动导管消融后复发机制的研究进展[J]. 内科理论与实践, 2022, 17(05): 396-399.

FEI Zhentao, CHEN Mu, LI Yigang. Research progress on mechanism of atrial fibrillation recurrence after catheter ablation[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 396-399.

参考文献47

[1]	Du X, Guo L, Xia S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China[J]. Heart, 2021, 107(7): 535-541. doi:10.1136/heartjnl-2020-317915 URL
[2]	Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS)[J]. Eur Heart J, 2021, 42(5): 373-498. doi:10.1093/eurheartj/ehaa612pmid:32860505
[3]	Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation[J]. N Engl J Med, 2021, 384(4): 305-315. doi:10.1056/NEJMoa2029980 URL
[4]	Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J]. Heart Rhythm, 2017, 14(10): e275-e444. doi:10.1016/j.hrthm.2017.05.012 URL
[5]	Wazni OM, Dandamudi G, Sood N, et al. Cryoballoon ablation as initial therapy for atrial fibrillation[J]. N Engl J Med, 2021, 384(4): 316-324. doi:10.1056/NEJMoa2029554 URL
[6]	Martin CA, Martin R, Gajendragadkar PR, et al. First clinical use of novel ablation catheter incorporating local impedance data[J]. J Cardiovasc Electrophysiol, 2018, 29(9): 1197-1206. doi:10.1111/jce.13654 URL
[7]	Kellnar A, Fichtner S, Mehr M, et al. Single-center experience of ultra-high-density mapping guided catheter ablation of focal atrial tachycardia[J]. Clin Cardiol, 2022, 45(3): 291-298. doi:10.1002/clc.23774pmid:35019172
[8]	Das M, Wynn GJ, Saeed Y, et al. Pulmonary vein re-isolation as a routine strategy regardless of symptoms[J]. JACC Clin Electrophysiol, 2017, 3(6): 602-611. doi:10.1016/j.jacep.2017.01.016 URL
[9]	Murray MI, Arnold A, Younis M, et al. Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials[J]. Clin Res Cardiol, 2018, 107(8): 658-669. doi:10.1007/s00392-018-1232-4 URL
[10]	Sørensen SK, Johannessen A, Worck R, et al. Radiofrequency versus cryoballoon catheter ablation for paroxysmal atrial fibrillation[J]. Circ Arrhythm Electrophysiol, 2021, 14(5): e009573. doi:10.1161/CIRCEP.120.009573 URL
[11]	Bollmann A, Ueberham L, Schuler E, et al. Cardiac tamponade in catheter ablation of atrial fibrillation: German-wide analysis of 21 141 procedures in the Helios atrial fibrillation ablation registry (SAFER)[J]. Europace, 2018, 20(12): 1944-1951. doi:10.1093/europace/euy131pmid:29982554
[12]	Kuck KH, Fürnkranz A, Chun KR, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE and ICE trial[J]. Eur Heart J, 2016, 37(38): 2858-2865. doi:10.1093/eurheartj/ehw285 URL
[13]	Kuck KH, Albenque JP, Chun KJ, et al. Repeat ablation for atrial fibrillation recurrence post cryoballoon or radiofrequency ablation in the FIRE and ICE trial[J]. Circ Arrhythm Electrophysiol, 2019, 12(6): e007247. doi:10.1161/CIRCEP.119.007247 URL
[14]	Lindemann F, Nedios S, Seewöster T, et al. Pulmonary vein isolation in atrial fibrillation using pulsed field ablation[J]. Herz, 2021, 46(4): 318-322. doi:10.1007/s00059-021-05047-w URL
[15]	Reddy VY, Dukkipati SR, Neuzil P, et al. Pulsed field ablation of paroxysmal atrial fibrillation[J]. JACC Clin Electrophysiol, 2021, 7(5): 614-627. doi:10.1016/j.jacep.2021.02.014 URL
[16]	Nakatani Y, Sridi-Cheniti S, Cheniti G, et al. Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation[J]. Europace, 2021, 23(11): 1767-1776. doi:10.1093/europace/euab155pmid:34240134
[17]	Gunawardene MA, Schaeffer BN, Jularic M, et al. Pulsed-field ablation combined with ultrahigh-density mapping in patients undergoing catheter ablation for atrial fibrillation: practical and electrophysiological considerations[J]. J Cardiovasc Electrophysiol, 2022, 33(3): 345-356. doi:10.1111/jce.15349 URL
[18]	Das M, Luik A, Shepherd E, et al. Local catheter impedance drop during pulmonary vein isolation predicts acute conduction block in patients with paroxysmal atrial fibrillation: initial results of the LOCALIZE clinical trial[J]. Europace, 2021, 23(7): 1042-1051. doi:10.1093/europace/euab004pmid:33550380
[19]	Okamatsu H, Okumura K, Kaneko S, et al. Ablation index-guided high-power radiofrequency application shortens the procedure time with similar outcomes to conventional power application in atrial fibrillation ablation[J]. Circ Rep, 2021, 3(10): 559-568. doi:10.1253/circrep.CR-21-0099pmid:34703933
[20]	Yasumoto K, Egami Y, Ukita K, et al. Ablation index-guided pulmonary vein isolation can reduce early recurrences of atrial tachyarrhythmias[J]. J Interv Card Elec-trophysiol, 2021.[Epub ahead of print].
[21]	Nery PB, Belliveau D, Nair GM, et al. Relationship between pulmonary vein reconnection and atrial fibrillation recurrence[J]. JACC Clin Electrophysiol, 2016, 2(4): 474-483. doi:10.1016/j.jacep.2016.02.003 URL
[22]	Dukkipati SR, Neuzil P, Kautzner J, et al. The durability of pulmonary vein isolation using the visually guided laser balloon catheter: multicenter results of pulmonary vein remapping studies[J]. Heart Rhythm, 2012, 9(6): 919-925. doi:10.1016/j.hrthm.2012.01.019pmid:22293143
[23]	Zhang T, Wang Y, Liang Z, et al. Effect of combined pulmonary vein and superior vena cava isolation on the outcome of second catheter ablation for paroxysmal atrial fibrillation[J]. Am J Cardiol, 2020, 125(12): 1845-1850. doi:S0002-9149(20)30280-0pmid:32305224
[24]	Omuro T, Yoshiga Y, Ueyama T, et al. An impact of superior vena cava isolation in non-paroxysmal atrial fibrillation patients with low voltage areas[J]. J Arrhythm, 2021, 37(4): 965-974. doi:10.1002/joa3.12552pmid:34386123
[25]	Romero J, Gabr M, Patel K, et al. Efficacy and safety of left atrial appendage electrical isolation during catheter ablation of atrial fibrillation: an updated meta-analysis[J]. Europace, 2021, 23(2): 226-237. doi:10.1093/europace/euaa266pmid:33324978
[26]	He B, Wang X, Zhao F, et al. The ligament of Marshall and arrhythmias[J]. Pacing Clin Electrophysiol, 2021, 44(5): 792-799. doi:10.1111/pace.14071 URL
[27]	Valderrábano M, Peterson LE, Bunge R, et al. Vein of Marshall ethanol infusion for persistent atrial fibrillation[J]. Am Heart J, 2019, 215: 52-61. doi:S0002-8703(19)30111-5pmid:31279972
[28]	Valderrábano M, Peterson LE, Swarup V, et al. Effect of catheter ablation with vein of Marshall ethanol infusionvscatheter ablation alone on persistent atrial fibrillation[J]. JAMA, 2020, 324(16): 1620-1628. doi:10.1001/jama.2020.16195pmid:33107945
[29]	Derval N, Duchateau J, Denis A, et al. Marshall bundle elimination, pulmonary vein isolation, and line completion for anatomical ablation of persistent atrial fibrillation(Marshall-PLAN)[J]. Heart Rhythm, 2021, 18(4): 529-537. doi:10.1016/j.hrthm.2020.12.023 URL
[30]	Li F, Sun JY, Wu LD, et al. The long-term outcomes of ablation with vein of Marshall ethanol infusionvs. ablation alone in patients with atrial fbrillation[J]. Front Cardiovasc Med, 2022, 9: 871654. doi:10.3389/fcvm.2022.871654 URL
[31]	Honarbakhsh S, Schilling RJ, Dhillon G, et al. A novel mapping system for panoramic mapping of the left atrium[J]. JACC Clin Electrophysiol, 2018, 4(1): 124-134. doi:S2405-500X(17)30949-0pmid:29387810
[32]	Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate[J]. J Am Coll Cardiol, 2004, 43(11): 2044-2053. pmid:15172410
[33]	Waranugraha Y, Rizal A, Setiawan D, et al. Additional complex fractionated atrial electrogram ablation does not improve the outcomes of non-paroxysmal atrial fibrillation[J]. Indian Heart J, 2021, 73(1): 63-73. doi:10.1016/j.ihj.2020.11.004pmid:33714411
[34]	Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation[J]. N Engl J Med, 2015, 372(19): 1812-1822. doi:10.1056/NEJMoa1408288 URL
[35]	Narayan SM, Krummen DE, Shivkumar K, et al. Treatment of atrial fibrillation by the ablation of localized sources[J]. J Am Coll Cardiol, 2012, 60(7): 628-636. doi:10.1016/j.jacc.2012.05.022pmid:22818076
[36]	Parameswaran R, Voskoboinik A, Gorelik A, et al. Clinical impact of rotor ablation in atrial fibrillation: a systematic review[J]. Europace, 2018, 20(7): 1099-1106. doi:10.1093/europace/eux370pmid:29340595
[37]	Tilz RR, Lenz C, Sommer P, et al. Focal impulse and rotor modulation ablationvs. pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation[J]. Europace, 2021, 23(5): 722-730. doi:10.1093/europace/euaa378 URL
[38]	Yamaguchi T, Marrouche NF. Recurrence post-atrial fibrillation ablation[J]. Circ Arrhythm Electrophysiol, 2018, 11(4): e006379. doi:10.1161/CIRCEP.118.006379 URL
[39]	Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation[J]. JAMA, 2014, 311(5): 498-506. doi:10.1001/jama.2014.3pmid:24496537
[40]	Kirstein B, Morris A, Baher A, et al. Magnetic resonance imaging-guided cryoballoon ablation for left atrial substrate modification in patients with atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2020, 31(7): 1587-1594. doi:10.1111/jce.14551 URL
[41]	Yamaguchi T, Tsuchiya T, Nagamoto Y, et al. Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation[J]. Europace, 2014, 16(4): 511-520. doi:10.1093/europace/eut265pmid:24078342
[42]	Kanda T, Masuda M, Asai M, et al. Extensive left atrial low-voltage area during initial ablation is associated with a poor clinical outcome even following multiple procedures[J]. J Atr Fibrillation, 2021, 14(2): 20200491.
[43]	Masuda M, Asai M, Iida O, et al. Additional low-voltage-area ablation in patients with paroxysmal atrial fibrillation[J]. J Am Heart Assoc, 2020, 9(13): e015927. doi:10.1161/JAHA.120.015927 URL
[44]	Sunaga A, Masuda M, Inoue K, et al. The efficacy and safety of left atrial low-voltage area guided ablation for recurrence prevention compared to pulmonary vein isolation alone in patients with persistent atrial fibrillation trial[J]. Clin Cardiol, 2021, 44(9): 1249-1255. doi:10.1002/clc.23677 URL
[45]	Liu HT, Yang CH, Lee HL, et al. Clinical outcomes of low-voltage area-guided left atrial linear ablation for non-paroxysmal atrial fibrillation patients[J]. PLoS One, 2021, 16(12): e0260834. doi:10.1371/journal.pone.0260834 URL
[46]	Parameswaran R, Kalman JM, Royse A, et al. Endocardial-epicardial phase mapping of prolonged persistent atrial fibrillation recordings[J]. Circ Arrhythm Electrophysiol, 2020, 13(8): e008512. doi:10.1161/CIRCEP.120.008512 URL
[47]	Hansen BJ, Zhao J, Csepe TA, et al. Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts[J]. Eur Heart J, 2015, 36(35): 2390-2401. doi:10.1093/eurheartj/ehv233pmid:26059724

心房颤动导管消融后复发机制的研究进展

Research progress on mechanism of atrial fibrillation recurrence after catheter ablation

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献47

相关文章15

编辑推荐

Metrics

本文评价

[1]	吴立群.大道至简——肺静脉隔离新技术[J]. 内科理论与实践, 2022, 17(05): 357-359.
[2]	李若谷.希氏束起搏的临床应用[J]. 内科理论与实践, 2022, 17(05): 360-364.
[3]	汤宝鹏, 张疆华, 郭衍楷.无导线起搏器临床应用进展[J]. 内科理论与实践, 2022, 17(05): 365-368.
[4]	陆林, 代杨, 王晓群, 吴立群, 张瑞岩, 沈卫峰.心血管转化研究的若干进展[J]. 内科理论与实践, 2022, 17(05): 369-372.
[5]	尹翔, 郑良荣.经皮左心耳封堵预防心房颤动卒中的研究进展[J]. 内科理论与实践, 2022, 17(05): 392-395.
[6]	张芝, 汤学超, 黄新苗, 秦永文.脉冲电场消融在心房颤动中的应用[J]. 内科理论与实践, 2022, 17(05): 400-404.
[7]	徐敏, 张京岚.非心脏手术后新发心房颤动患者的相关临床分析[J]. 内科理论与实践, 2022, 17(04): 334-336.
[8]	白英, 刘心遥, 张溪林, 高兆芳, 史旭波, 邓可武.规范抗凝对心房颤动住院患者预后的影响[J]. 内科理论与实践, 2021, 16(06): 409-412.
[9]	李翔, 金奇, 潘文麒, 贾康妮, 张凝, 林长坚, 凌天佑, 陈康, 谢玉才, 吴立群.磁导航指导特发性室性心律失常消融手术的学习曲线分析[J]. 内科理论与实践, 2021, 16(03): 167-171.
[10]	罗晓颖, 许燕, 张凤如, 吴立群, 戚文航.P波离散度和N端脑钠肽前体预测房颤冷冻球囊导管消融术后复发的价值[J]. 诊断学理论与实践, 2020, 19(1): 32-36.
[11]	陈信光, 张凤祥.特定人群室性心律失常风险评估进展及策略[J]. 诊断学理论与实践, 2020, 19(06): 549-554.
[12]	刘彤, 王鑫.心房颤动预后不良风险的评估策略[J]. 诊断学理论与实践, 2020, 19(06): 555-558.
[13]	罗晓颖, 许燕, 张建盛, 吴立群, 戚文航.N端脑钠肽前体预测首次急性心肌梗死后新发心房颤动的价值研究[J]. 诊断学理论与实践, 2020, 19(03): 303-307.
[14]	王晨琛, 杨文波, 华玮, 陈晔芬, 苏秀秀, 龚俊世, 方跃华.左心耳解剖形态、功能与非瓣膜性心房颤动患者脑卒中发生风险的相关性研究[J]. 诊断学理论与实践, 2020, 19(02): 151-156.
[15]	谷阳, 胡晓, 王婧, 王丙剑.以问题为基础的教学结合微课教学模式在心血管病学教学中的应用探讨[J]. 诊断学理论与实践, 2019, 18(06): 715-717.